FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 67 filers reported holding FORTRESS BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,000 | 0.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000 | -37.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $27,000 | -46.0% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $50,000 | -21.9% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $64,000 | -9.9% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $71,000 | 0.0% | 20,000 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $71,000 | +12.7% | 20,000 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $63,000 | -22.2% | 20,000 | 0.0% | 0.00% | -42.9% |
| Q3 2020 | $81,000 | +50.0% | 20,000 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $54,000 | +42.1% | 20,000 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $38,000 | -25.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $51,000 | +82.1% | 20,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $28,000 | -6.7% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $30,000 | -16.7% | 20,000 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $36,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,887,500 | $12,323,000 | 1.61% |
| Nantahala Capital Management | 8,680,909 | $27,518,000 | 0.85% |
| SHIKIAR ASSET MANAGEMENT INC | 558,500 | $1,770,000 | 0.64% |
| CPWM, LLC | 506,267 | $1,605,000 | 0.15% |
| Sandbox Financial Partners, LLC | 14,650 | $46,000 | 0.04% |
| Sepio Capital, LP | 134,748 | $427,000 | 0.04% |
| 683 Capital Management, LLC | 200,000 | $635,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 22,928 | $73,000 | 0.01% |
| Virtu Financial LLC | 33,333 | $106,000 | 0.01% |
| B. Riley Wealth Advisors, Inc. | 55,510 | $176,000 | 0.01% |